Monday, November 23, 2009, 3:56pm SGT - The Singapore stock market closes in 1 hour and 4 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Cumberland Pharmaceuticals, Inc. (CPIX)

On Nov 21: 15.44 USD  Up 0.82 (5.61%)  
 MORE ON CPIX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Cumberland Pharmaceuticals Inc. (NasdaqNM:CPIX) Delayed quote dataEdit
After Hours: 14.86 Down 0.58 (3.77%) as of 5:11am SGT on 11/21/09
Last Trade:15.44 USD
Trade Time:Nov 21
Change:Up 0.82 (5.61%)
Prev Close:14.62
Open:14.90
Bid:14.35 x 100
Ask:N/A
1y Target Est:20.67
Day's Range:14.32 - 15.44
52wk Range:11.78 - 17.75
Volume:48,409
Avg Vol (3m):65,815.1
Market Cap:310.87M
P/E (ttm):67.42
EPS (ttm):0.23
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m 
Use Y! Toolbar to track stocks
 Add CPIX to Portfolio   Download Data

 HEADLINES 
•CUMBERLAND PHARMACEUTICALS INC Financials
EDGAR Online Financials (Wed, Nov 18)
•CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
•New Star Analyst Rankings for Cumberland Pharmaceuticals Inc.
StarMine (Wed, Nov 11)
•CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
EDGAR Online (Wed, Nov 11)
•Cumberland Pharmaceuticals earnings up 6% in 3Q
at bizjournals.com (Wed, Nov 11)
•Cumberland 3Q profit rose on Caldolor sales
AP (Wed, Nov 11)
•UPDATE - Cumberland profit tops estimate, shares climb
at Reuters (Tue, Nov 10)
•Cumberland Pharmaceuticals Reports 58% Increase in Net Revenue With Third Quarter 2009 Financial Results
PR Newswire (Tue, Nov 10)
•Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
PR Newswire (Mon, Nov 2)
•Cumberland Pharma gets pain drug marketing partner
AP (Fri, Oct 30)
More Headlines for CPIX...
 ANALYST 
EPS Est (next year) (Dec-09) :0.20
EPS Est (in 2 years) (Dec-10) :0.48
Avg Rec (current)*:1.5
PEG Ratio:1.02
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices